hypericum has been researched along with Neuralgia* in 4 studies
1 trial(s) available for hypericum and Neuralgia
Article | Year |
---|---|
St. John's wort has no effect on pain in polyneuropathy.
Tricyclic antidepressants are the mainstay of treatment of painful polyneuropathy but cannot be used in a substantial number of patients. St. John's wort is a herbal antidepressant, which may act via mechanisms similar to the tricyclics. The aim of this study was to test if St. John's wort would relieve painful polyneuropathy. The study design was randomized, double-blind, placebo-controlled and cross-over. Fifty-four patients were assigned to one of the two treatment sequences. The daily dose of St. John's wort was three tablets each containing 900 microg totalhypericin. During the two treatment periods of 5 weeks duration, patients rated constant pain, lancinating pain paroxysms, touch-evoked pain and pain on pressure by use of 0--10 point numeric rating scales. Forty-seven patients -- 18 diabetics and 29 non-diabetics -- completed the study. There was a trend of lower total pain score (sum of the individual pain scores) on St. John's wort than on placebo (median 14 vs. 15, P=0.05). None of the individual pain ratings were significantly changed by St. John's wort as compared to placebo (P=0.09--0.33). Complete, good or moderate pain relief was experienced by nine patients with St. John's wort and two with placebo (P=0.07). In conclusion, St. John's wort has no significant effect on pain in polyneuropathy. Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Neuralgia; Pain Measurement; Phytotherapy; Plants, Medicinal; Polyneuropathies; Treatment Failure | 2001 |
3 other study(ies) available for hypericum and Neuralgia
Article | Year |
---|---|
Nanoencapsulation and characterisation of
This work aimed to encapsulate. Hydroalcoholic extract of. Particle size, zeta potential, %EE, and LC were 104.7 ± 1.529 nm, -8.93 ± 1.71 mV, 87.23 ± 1.3%, and 53.12 ± 1.7%, respectively. TEM revealed well-formed and distinct vesicles. NPHPE (NPs of HPE) was significantly more effective than HPE in reducing PSNL-inducing pain. Antioxidant levels and sciatic nerve histology were reversed to normal with NPHPE.. This study demonstrates that encapsulating HPE with phytosomes is an effective therapeutic approach for neuropathic pain. Topics: Antineoplastic Agents; Antioxidants; Hypericum; Neuralgia; Plant Extracts; Plant Oils | 2023 |
St. John's Wort Potentiates anti-Nociceptive Effects of Morphine in Mice Models of Neuropathic Pain.
In this study, we compared the efficacy of a combination of PKC-blocker St. John's Wort (SJW) and morphine in mice with painful antiretroviral (2,3-dideoxycitidine [ddC]) and chemotherapic (oxaliplatin) neuropathy.. Morphine (1 and 5 mg/Kg i.p.), SJW (1 and 5 mg/Kg o.s.), or their combination was administered by systemic injection, and antinociception was determined by using the hot and cold plate tests.. Here we demonstrate the ability of SJW to relieve neuropathic pain in mice neuropathic models and a potentiation of morphine antinociception in thermal pain. The potentiating effect shown by SJW was not secondary to its antinociceptive activity as the increase of the morphine antinociceptive effect was produced at a dose (1mg/kg o.s.) devoid of any capability to modulate the pain threshold in neuropathic pain mice. Further examinations of the SJW main components revealed that hypericin was responsible for the potentiating properties whereas flavonoids were ineffective.. These results show that SJW has notable antinociceptive activity for both neuropathic pain models and could be used in neuropathic pain relief alone or in combination with morphine. These data support the utility of combination SJW/opioid therapy in pain management for antinociceptive efficacy by enhancing opioid analgesia. Topics: Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hypericum; Male; Mice; Morphine; Neuralgia; Pain Measurement; Plant Extracts; Reaction Time; Treatment Outcome | 2017 |
Toxicity of Hypericum perforatum.
Topics: Adult; Animals; Complementary Therapies; Cricetinae; DNA; Female; Humans; Hypericum; Male; Neuralgia; Oocytes; Phytotherapy; Plants, Medicinal; Spermatozoa; Sunlight | 1999 |